Microalgae Market Size, Share, and Trends 2024 to 2034

The global microalgae market size is accounted at USD 13.85 billion in 2025 and is forecasted to hit around USD 27.54 billion by 2034, representing a CAGR of 7.95% from 2025 to 2034. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : February 2025
  • Report Code : 4637
  • Category : Food and Beverages

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID-19 Impact on Microalgae Market 

5.1. COVID-19 Landscape: Microalgae Industry Impact

5.2. COVID-19 - Impact Assessment for the Industry

5.3. COVID-19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Microalgae Market, By Species

8.1. Microalgae Market Revenue and Volume, by Species

8.1.1 Spirulina

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Chlorella

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Dunaliella

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Haematococcus

8.1.4.1. Market Revenue and Volume Forecast

8.1.5. Crypthecodinium

8.1.5.1. Market Revenue and Volume Forecast

8.1.6. Schizochytrium

8.1.6.1. Market Revenue and Volume Forecast

8.1.7. Euglena

8.1.7.1. Market Revenue and Volume Forecast

8.1.8. Phaeydactelum     

8.1.8.1. Market Revenue and Volume Forecast

8.1.9. Others

8.1.9.1. Market Revenue and Volume Forecast

Chapter 9. Global Microalgae Market, By Source

9.1. Microalgae Market Revenue and Volume, by Source

9.1.1. Marine Water

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Fresh Water

9.1.2.1. Market Revenue and Volume Forecast

Chapter 10. Global Microalgae Market, By End-use Application 

10.1. Microalgae Market Revenue and Volume, by End-use Application

10.1.1. Food and Beverages Sector

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Health and Medical Sector

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Animal Feed Sector

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Pet Food Sector

10.1.4.1. Market Revenue and Volume Forecast

10.1.5. Cosmetics and Personal Care Sector

10.1.5.1. Market Revenue and Volume Forecast

10.1.6. Fertilizers Sector

10.1.6.1. Market Revenue and Volume Forecast

Chapter 11. Global Microalgae Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Volume Forecast, by Species

11.1.2. Market Revenue and Volume Forecast, by Source

11.1.3. Market Revenue and Volume Forecast, by End-use Application

11.1.4. U.S.

11.1.4.1. Market Revenue and Volume Forecast, by Species

11.1.4.2. Market Revenue and Volume Forecast, by Source

11.1.4.3. Market Revenue and Volume Forecast, by End-use Application

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Volume Forecast, by Species

11.1.5.2. Market Revenue and Volume Forecast, by Source

11.1.5.3. Market Revenue and Volume Forecast, by End-use Application

11.2. Europe

11.2.1. Market Revenue and Volume Forecast, by Species

11.2.2. Market Revenue and Volume Forecast, by Source

11.2.3. Market Revenue and Volume Forecast, by End-use Application

11.2.4. UK

11.2.4.1. Market Revenue and Volume Forecast, by Species

11.2.4.2. Market Revenue and Volume Forecast, by Source

11.2.4.3. Market Revenue and Volume Forecast, by End-use Application

11.2.5. Germany

11.2.5.1. Market Revenue and Volume Forecast, by Species

11.2.5.2. Market Revenue and Volume Forecast, by Source

11.2.5.3. Market Revenue and Volume Forecast, by End-use Application

11.2.6. France

11.2.6.1. Market Revenue and Volume Forecast, by Species

11.2.6.2. Market Revenue and Volume Forecast, by Source

11.2.6.3. Market Revenue and Volume Forecast, by End-use Application

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Volume Forecast, by Species

11.2.7.2. Market Revenue and Volume Forecast, by Source

11.2.7.3. Market Revenue and Volume Forecast, by End-use Application

11.3. APAC

11.3.1. Market Revenue and Volume Forecast, by Species

11.3.2. Market Revenue and Volume Forecast, by Source

11.3.3. Market Revenue and Volume Forecast, by End-use Application

11.3.4. India

11.3.4.1. Market Revenue and Volume Forecast, by Species

11.3.4.2. Market Revenue and Volume Forecast, by Source

11.3.4.3. Market Revenue and Volume Forecast, by End-use Application

11.3.5. China

11.3.5.1. Market Revenue and Volume Forecast, by Species

11.3.5.2. Market Revenue and Volume Forecast, by Source

11.3.5.3. Market Revenue and Volume Forecast, by End-use Application

11.3.6. Japan

11.3.6.1. Market Revenue and Volume Forecast, by Species

11.3.6.2. Market Revenue and Volume Forecast, by Source

11.3.6.3. Market Revenue and Volume Forecast, by End-use Application

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Volume Forecast, by Species

11.3.7.2. Market Revenue and Volume Forecast, by Source

11.3.7.3. Market Revenue and Volume Forecast, by End-use Application

11.4. MEA

11.4.1. Market Revenue and Volume Forecast, by Species

11.4.2. Market Revenue and Volume Forecast, by Source

11.4.3. Market Revenue and Volume Forecast, by End-use Application

11.4.4. GCC

11.4.4.1. Market Revenue and Volume Forecast, by Species

11.4.4.2. Market Revenue and Volume Forecast, by Source

11.4.4.3. Market Revenue and Volume Forecast, by End-use Application

11.4.5. North Africa

11.4.5.1. Market Revenue and Volume Forecast, by Species

11.4.5.2. Market Revenue and Volume Forecast, by Source

11.4.5.3. Market Revenue and Volume Forecast, by End-use Application

11.4.6. South Africa

11.4.6.1. Market Revenue and Volume Forecast, by Species

11.4.6.2. Market Revenue and Volume Forecast, by Source

11.4.6.3. Market Revenue and Volume Forecast, by End-use Application

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Volume Forecast, by Species

11.4.7.2. Market Revenue and Volume Forecast, by Source

11.4.7.3. Market Revenue and Volume Forecast, by End-use Application

11.5. Latin America

11.5.1. Market Revenue and Volume Forecast, by Species

11.5.2. Market Revenue and Volume Forecast, by Source

11.5.3. Market Revenue and Volume Forecast, by End-use Application

11.5.4. Brazil

11.5.4.1. Market Revenue and Volume Forecast, by Species

11.5.4.2. Market Revenue and Volume Forecast, by Source

11.5.4.3. Market Revenue and Volume Forecast, by End-use Application

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Volume Forecast, by Species

11.5.5.2. Market Revenue and Volume Forecast, by Source

11.5.5.3. Market Revenue and Volume Forecast, by End-use Application

Chapter 12. Company Profiles

12.1. Bristol Myers Squibb Company

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Amgen Inc.

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Regeneron Pharmaceuticals Inc

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Vertex Pharmaceuticals Incorporated

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Gilead Sciences Inc.

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Moderna Inc.

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. BioNTech SE

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. WuXi STA

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Aragen Bioscience Inc.

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. MedChemExpress LLC

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global microalgae market size is expected to increase USD 27.54 billion by 2034 from USD 12.81 billion in 2024.

The global microalgae market will register growth rate of 7.95% between 2025 and 2034.

The major players operating in the microalgae market are Bristol Myers Squibb Company, Amgen Inc., Regeneron Pharmaceuticals Inc, Vertex Pharmaceuticals Incorporated, Gilead Sciences Inc., Moderna Inc. BioNTech SE, WuXi STA, Aragen Bioscience Inc., MedChemExpress LLC, Promega Corporation, Sai Life Sciences Limited, BioAscent Discovery Limited, SRI International, Peak Protein Ltd., Sygnature Discovery Limited, Aptuit LLC, ChemPartener Corporation, BioDuro LLC, Concept Life Sciences Group Limited, Selcia Limited, Pharmaron Beijing Co. Ltd, Viva Biotech Holdings, and Others.

The driving factors of the microalgae market are the Rising vegetarians and preference for microalgae-sourced products.

North America region will lead the global microalgae market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client